Somatotropic Axis Dysfunction in Non-Alcoholic Fatty Liver Disease: Beneficial Hepatic and Systemic Effects of Hormone Supplementation

Reduced Growth Hormone Secretion is Associated with Nonalcoholic Fatty Liver Disease in Obese Children

(2018) Shuang Liang et al.   HORMONE AND METABOLIC RESEARCH

The role of growth hormone receptor in β cell function

(2017) Shuang Wang et al.   GROWTH HORMONE & IGF RESEARCH

Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis

(2017) Rahima A. Bhanji et al.   HEPATOLOGY

The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease

(2017) Sayaka Chishima et al.   INTERNAL MEDICINE

The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver

(2017) Yutaka Takahashi   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle

(2017) Eleonora Poggiogalle et al.   WORLD JOURNAL OF GASTROENTEROLOGY

The Association Between IGF-1 Levels and the Histologic Severity of Nonalcoholic Fatty Liver Disease

(2017) Laura E Dichtel et al.   Clinical and Translational Gastroenterology

Mice overexpressing growth hormone exhibit increased skeletal muscle myostatin and MuRF1 with attenuation of muscle mass

(2017) Leslie A. Consitt et al.   Skeletal Muscle

The modulation of adiponectin by STAT5-activating hormones

(2016) Ursula A. White et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Mitogenic signaling pathways in the liver of growth hormone (GH)-overexpressing mice during the growth period

(2016) Carolina S. Martinez et al.   CELL CYCLE

Diet-Induced Nonalcoholic Fatty Liver Disease Is Associated with Sarcopenia and Decreased Serum Insulin-Like Growth Factor-1

(2016) Daniel Cabrera et al.   DIGESTIVE DISEASES AND SCIENCES

Insulin resistance and sarcopenia: mechanistic links between common co-morbidities

(2016) Mark E Cleasby et al.   JOURNAL OF ENDOCRINOLOGY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

High Fat Diet-Induced Skeletal Muscle Wasting Is Decreased by Mesenchymal Stem Cells Administration: Implications on Oxidative Stress, Ubiquitin Proteasome Pathway Activation, and Myonuclear Apoptosis

(2016) Johanna Abrigo et al.   Oxidative Medicine and Cellular Longevity

The Impact of Adipose Tissue on Insulin Resistance in Acromegaly

(2016) Nicoleta Cristina Olarescu et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner

(2016) Hitoshi Nishizawa et al.   Scientific Reports

Growth Hormone Inhibits Hepatic De Novo Lipogenesis in Adult Mice

(2015) Jose Cordoba-Chacon et al.   DIABETES

Decreased muscle mass in nonalcoholic fatty liver disease: New evidence of a link between growth hormone and fatty liver disease?

(2014) Maureen M.J. Guichelaar et al.   HEPATOLOGY

Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 Diabetes

(2013) Andreas L. Birkenfeld et al.   HEPATOLOGY

Relationship between sarcopenia and nonalcoholic fatty liver disease: The Korean Sarcopenic Obesity Study

(2013) Ho Cheol Hong et al.   HEPATOLOGY

Insulin-Like Growth Factor-I, Inflammatory Proteins, and Fibrosis in Subjects With Nonalcoholic Fatty Liver Disease

(2013) Marta Letizia Hribal et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Measuring the Strength of Mice

(2013) Robert M.J. Deacon   Jove-Journal of Visualized Experiments

Growth Hormone and the Cardiovascular System

(2012) Christopher R. Palmeiro et al.   Cardiology in Review

Non-alcoholic fatty liver disease and insulin resistance: From bench to bedside

(2012) K. Gariani et al.   DIABETES & METABOLISM

Metabolic Actions of Insulin-Like Growth Factor-I in Normal Physiology and Diabetes

(2012) David R. Clemmons   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications

(2012) Kenneth Cusi   GASTROENTEROLOGY

Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients

(2011) Edith Koehler et al.   LIVER INTERNATIONAL

Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexia

(2011) Katja Trobec et al.   Journal of Cachexia Sarcopenia and Muscle

Epidemiology of Non-Alcoholic Fatty Liver Disease

(2010) Stefano Bellentani et al.   DIGESTIVE DISEASES

The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis

(2010) Sebastio Perrini et al.   JOURNAL OF ENDOCRINOLOGY

Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics

(2010) Arnoldo Riquelme et al.   LIVER INTERNATIONAL

Liver disease: an overlooked complication of diabetes mellitus

(2010) Marco Arrese   Nature Reviews Endocrinology

Epidemiology and Natural History of Non-Alcoholic Steatohepatitis

(2009) Curtis K. Argo et al.   Clinics in Liver Disease

Growth hormone improves body composition, fasting blood glucose, glucose tolerance and liver triacylglycerol in a mouse model of diet-induced obesity and type 2 diabetes

(2009) E. O. List et al.   DIABETOLOGIA

The Role of Liver-Derived Insulin-Like Growth Factor-I

(2009) Claes Ohlsson et al.   ENDOCRINE REVIEWS

Adipokines in liver diseases

(2009) Fabio Marra et al.   HEPATOLOGY

Adipocytokines and liver disease

(2008) Yoshihiro Kamada et al.   JOURNAL OF GASTROENTEROLOGY